• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

Innovate IndianaNews and information on how IU is driving innovation, entrepreneurship and economic development

Article details IURTC's efforts to help bring an IU researcher's antibiotic derivative to market

Posted on January 6, 2016 by Bill W. Hornaday

ShowProfileImage
Dr. Bruce Molitoris

Back in mid-2015, the Indiana University Research and Technology Corp. struck a deal with California-based La Jolla Pharmaceutical Co. to acquire intellectual property rights to “next-generation” offshoots of gentamicin — a hospital-grade antibiotic which has limited use because of its toxicity.

Because the offshoots have shown signs of lacking such toxicity, they hold promise in treating such diseases as cystic fibrosis and Duchenne’s muscular dystrophy. Through another agreement between IURTC and the University of Alabama at Birmingham, La Jolla also obtained the option to apply gentamicin derivatives toward treatment of such diseases.

In this week’s issue of the Indianapolis Business Journal, writer Sam Stall takes a detailed look at how IU Department of Medicine professor Dr. Bruce Molitoris and the IURTC have worked since 2006 to try to commercialize the compound.

“You always need an office like this to handle patenting, or else I think it would rarely get done,” Molitoris, a professor of medicine and integrative and cellular physiology, told the IBJ in the Jan. 2 article. “If testing bears out, it has the potential to treat diseases that affect 30 million in the U.S. and 300 million worldwide.”

Read more about the work of Molitoris and the IURTC here:

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Filed under: Economic DevelopmentTagged Intellectual property, IU School of Medicine, Life Sciences, Technology Transfer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Innovate Indiana Button

Search Innovate Indiana

About Innovate Indiana

Join us as we highlight how IU innovation is accelerating economic growth in Indiana and beyond and creating a culture of entrepreneurship across the Hoosier state.

Innovate Indiana is maintained by the Indiana University Office of the Vice President for University Relations.

Subscribe to the Innovate Indiana Blog

Sign up to receive regular updates from Innovate Indiana Blog

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent Posts

  • IU, NSWC Crane partner on research initiative to help secure Navy's AI, machine learning systems February 1, 2023
  • IU’s, state’s participation in first-ever NBA games in India helps alumni investors score, spotlights potential economic benefits of engagement with country’s growing venture capital landscape January 31, 2023
  • IU researchers seek to commercialize AI tool to identify undiagnosed cases of early-stage Alzheimer’s disease and related dementia January 24, 2023
  • IU researchers win Translational Research grant for plastic neutron shield material technology January 20, 2023
  • IU-affiliated startup wins the Regional Pre-Seed Award from Elevate Nexus Southern Region Pitch Competition January 17, 2023

Categories

Bookmarks

  • Innovate Indiana website
  • IU Center on Representative Government
  • IU Impact
  • IU Innovation and Commercialization Office
  • IU Office of the Vice President for Research
  • IU Office of the Vice President for University Relations
  • IU Ventures

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.